Skip to Content
Merck
CN

Key Documents

View All Documentation

14506

Bis(hexamethylene)triamine

technical, ≥95% (GC)

Synonym(s):

6,6′-Iminodihexylamine, Bis(6-aminohexyl)amine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
NH2(CH2)6NH(CH2)6NH2
CAS Number:
143-23-7
Molecular Weight:
215.38
EC Number:
205-593-1
UNSPSC Code:
12352100
MDL number:
MFCD00010448
Beilstein/REAXYS Number:
2323517
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

vapor pressure

<0.01 mmHg ( 25 °C)

grade

technical

assay

≥95% (GC)

refractive index

n20/D 1.49 (lit.)

bp

163-165 °C/4 mmHg (lit.)

mp

32-37 °C, 33-36 °C (lit.)

density

0.85 g/mL at 20 °C (lit.)

storage temp.

2-8°C

SMILES string

NCCCCCCNCCCCCCN

InChI

1S/C12H29N3/c13-9-5-1-3-7-11-15-12-8-4-2-6-10-14/h15H,1-14H2

InChI key

MRNZSTMRDWRNNR-UHFFFAOYSA-N

Other Notes

This product has been replaced by 421960-ALDRICH | Bis(hexamethylene)triamine high purity

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1A - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 1

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xiaoning Li et al.
Bioconjugate chemistry, 26(3), 520-528 (2015-02-26)
Subcutaneous delivery is one of the preferred administration routes for therapeutic monoclonal antibodies (mAbs). High antibody dosing requirements and small injection volumes necessitate formulation and delivery of highly concentrated mAb solutions. Such elevated antibody concentrations can lead to undesirable solution